Clinical Trials on Rheumatoid Arthritis

Total 11400 results

Hospital General Universitario Gregorio Marañon
Roche Pharma AG

Unknown

Reduced Ultrasound Counts in Rheumatoid Arthritis

Rheumatoid Arthritis

Spain
Genentech, Inc.
Hoffmann-La Roche

Completed

A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis (SERENE)

Rheumatoid Arthritis
Pope Research Corporation
Hoffmann-La Roche

Withdrawn

The Durability of Early RA Disease Control After Tocilizumab Withdrawal: A Canadian Experience

Rheumatoid Arthritis
Merck Sharp & Dohme LLC
AESCA Pharma GmbH

Terminated

Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1) (TERMINATED)

Rheumatoid Arthritis
Brigham and Women's Hospital
Eli Lilly and Company

Completed

Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial (TERA)

Rheumatoid Arthritis

United States
Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid Arthritis (GRGDRA)

Rheumatoid Arthritis

China
Chengdu PLA General Hospital

Unknown

Qingkailing Injection Versus Puerarin Injection on Withdrawal Rate of Corticosteroids in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

China
Chengdu PLA General Hospital

Unknown

Cognitive-behavioral Treatment for Rheumatoid Arthritis

Rheumatoid Arthritis

China
Biocad

Completed

Study of Safety and Efficacy of BCD-020 Comparing to MabThera in Patients With Rheumatoid Arthritis (BIORA)

Rheumatoid Arthritis

India, Russian Federation, Belarus, Ukraine
Hoffmann-La Roche
Genentech, Inc.

Completed

Extension Study to Assess the Efficacy and Safety of Repeat Treatment With Rituximab (MabThera) in Participants With Active Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Belgium, Germany, Poland, Spain, United States, Canada, Mexico, New Zealand, United Kingdom, Finland, Israel, Italy, Sweden, Australia, Brazil, Czech Republic
Hoffmann-La Roche

Completed

A Study of the Efficacy and Safety of Tocilizumab in Adults With Rheumatoid Arthritis.

Rheumatoid Arthritis

Israel
IRCCS Policlinico S. Matteo

Completed

Prospective Study on Intensive Early Rheumatoid Arthritis Treatment (CURE)

Rheumatoid Arthritis

Italy
Pfizer

Completed

Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan

Rheumatoid Arthritis

Japan
Hoffmann-La Roche

Completed

A Non-Interventional Study Evaluating Rheumatoid Arthritis Participants Treated With Tocilizumab (RoActemra/Actemra)

Rheumatoid Arthritis

Serbia
Hospital Universitario de Canarias
Roche Pharma AG

Unknown

Effect of Monoclonal Anti-IL6 Antibody (Tocilizumab) on the Cardiovascular Risk in Patients With Rheumatoid Arthritis (TOCRIVAR)

Rheumatoid Arthritis

Spain
Hoffmann-La Roche

Completed

A Long-Term Extension Study of WA19926 on the Safety of Tocilizumab (RoActemra/Actemra) in Participants With Early Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis

France
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Completed

Use-Results Survey for ORENCIA® Subcutaneous Injection 125mg Syringe 1mL

Rheumatoid Arthritis

Japan
Amgen

Completed

Long-Term Assessment of Safety and Physical Function With AMG 108 in RA

Rheumatoid Arthritis
Bristol-Myers Squibb

Completed

Safety Study of Abatacept to Treat Rheumatoid Arthritis (A)

Rheumatoid Arthritis
Hoffmann-La Roche

Completed

A Study of Tocilizumab in Participants With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Non-Biological Disease-modifying Anti-rheumatic Drugs (DMARDs)

Rheumatoid Arthritis

Montenegro
University of Arizona
National Institutes of Health (NIH); Vanderbilt University; National Center for...

Terminated

Curcuma Longa L in Rheumatoid Arthritis (CLaRA)

Rheumatoid Arthritis

United States
Hoffmann-La Roche

Completed

A Long-Term Extension Study of WA22762 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA).

Rheumatoid Arthritis

France
MedImmune LLC
Daiichi Sankyo Co., Ltd.

Completed

Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

United States
AbbVie

Completed

A Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

Rheumatoid Arthritis
Fundació Institut de Recerca de l'Hospital de la...
Roche Pharma AG

Completed

Regulation of the Immune System in Response to the Treatment With Tocilizumab in Rheumatoid Arthritis Patients

Rheumatoid Arthritis

Spain
Hoffmann-La Roche

Completed

A Long-Term Safety Extension Study of WA19926 in Participants With Rheumatoid Arthritis

Rheumatoid Arthritis

Hungary
Hoffmann-La Roche

Completed

A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) Treatment in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Panama, Costa Rica, Dominican Republic, Guatemala
Hoffmann-La Roche

Completed

A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy

Rheumatoid Arthritis

Germany, Poland, United States, Australia, Brazil, Canada, Estonia, Greece, Ireland, Mexico, New Zealand, South Africa, Spain, United Kingdom
Hoffmann-La Roche

Terminated

A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis (MONACO)

Rheumatoid Arthritis

Portugal
Hoffmann-La Roche

Completed

A Retrospective Chart Review on the Use of Biologics in Monotherapy for the Treatment of Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

United Kingdom
Hoffmann-La Roche

Completed

An Observational Study of Glucocorticoid Use in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab)

Rheumatoid Arthritis

France
Hoffmann-La Roche

Completed

A Study Assessing the Safety and Efficacy of Subcutaneous RoActemra/Actemra Alone or in Combination With Non-biologic Antirheumatics in Rhuematoid Arthritis Patients in Latin America With Inadequate Response to Non-biologic Antirheumatic Drugs.

Rheumatoid Arthritis

Brazil, Colombia, Argentina, Dominican Republic, Mexico, Venezuela
Hoffmann-La Roche

Completed

A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy

Rheumatoid Arthritis

France, Germany, Italy, Australia, United States, Canada, Mexico, United Kingdom, Sweden, Belgium, Switzerland, Netherlands, Puerto Rico, Iceland
Hoffmann-La Roche

Completed

An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)

Rheumatoid Arthritis

Finland
Hoffmann-La Roche

Completed

An Observational Study of RoActemra/Actemra (Tocilizumab) in Smoking Versus Non-Smoking Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Norway, Sweden
Hoffmann-La Roche

Completed

An Observational Study of Dosage Patterns in Routine Clinical Practice in Patients With Rheumatoid Arthritis (ACT-LIFE)

Rheumatoid Arthritis

Spain, United States
Hoffmann-La Roche

Completed

Local, Non-Interventional Study of RoActemra (Tocilizumab) in Poland (ACT-POL): First-Line Treatment in Routine Clinical Practice of Participants With Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Poland
Hoffmann-La Roche

Completed

An Observational Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis

Greece
Hoffmann-La Roche

Completed

A Study of Subcutaneously Administered Tocilizumab in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Canada, New Zealand, Spain
Hoffmann-La Roche

Completed

A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis

Indonesia
Hoffmann-La Roche

Completed

Use of Tocilizumab for Rheumatoid Arthritis (RA) in Daily Routine

Rheumatoid Arthritis

Germany
Genentech, Inc.

Completed

A Long-Term Extension Study of WA22762 and NA25220 of Subcutaneous (SC) Tocilizumab (TCZ) in Moderate to Severe Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

United States, Puerto Rico
Hoffmann-La Roche

Completed

An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis

Rheumatoid Arthritis

Australia
Bristol-Myers Squibb

Completed

Predictors of Adherence to Orencia

Rheumatoid Arthritis
Guang'anmen Hospital of China Academy of Chinese...

Unknown

Efficacy and Safety of Traditional Chinese Medicine (TCM) Comprehensive Therapy in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

China
Eli Lilly and Company

Completed

A Study in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Germany, United States, Romania, Russian Federation, Argentina, Peru, Poland, Taiwan, Korea, Republic of, India, Chile
Eli Lilly and Company

Completed

A Study of LY2439821 in Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Hoffmann-La Roche

Completed

A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a TNF-Blocker.

Rheumatoid Arthritis

Hungary
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Multiple Doses Escalation Study of SHR0302 in Rheumatoid Arthritis (RA) Patients

Rheumatoid Arthritis

China
Hoffmann-La Roche

Completed

An Observational Study in Clinical Practice Management of Patients With Biological Drugs in Monotherapy

Rheumatoid Arthritis

Spain

3

Subscribe